$ARVN
Arvinas Inc

2021 Q4 Form 10-K Financial Statement

#000162828022004262 Filed on February 28, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 2020 Q4
Revenue $26.33M $46.70M $2.220M
YoY Change 1086.1% 114.22% -54.63%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $18.86M $61.60M $12.23M
YoY Change 54.19% 60.84% 68.23%
% of Gross Profit
Research & Development $61.92M $180.4M $33.20M
YoY Change 86.5% 66.42% 62.63%
% of Gross Profit
Depreciation & Amortization $1.288M $4.800M $1.060M
YoY Change 21.51% 50.0% 96.3%
% of Gross Profit
Operating Expenses $80.78M $242.0M $45.43M
YoY Change 77.8% 64.96% 64.11%
Operating Profit -$195.3M
YoY Change 56.37%
Interest Expense $653.4K $100.0K $500.0K
YoY Change 30.68% 0.0% 2976.92%
% of Operating Profit
Other Income/Expense, Net $796.5K $4.300M $1.160M
YoY Change -31.34% -23.21% -33.42%
Pretax Income -$53.00M -$191.0M -$41.55M
YoY Change 27.55% 60.06% 97.39%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$53.00M -$191.0M -$41.55M
YoY Change 27.55% 60.1% 97.41%
Net Earnings / Revenue -201.27% -408.99% -1871.62%
Basic Earnings Per Share -$3.82
Diluted Earnings Per Share -$1.006M -$3.82 -$994.5K
COMMON SHARES
Basic Shares Outstanding 50.00M shares
Diluted Shares Outstanding 50.00M shares

Balance Sheet

Concept 2021 Q4 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.503B $1.503B $688.5M
YoY Change 118.24% 118.24% 145.11%
Cash & Equivalents $108.3M $108.3M $588.4M
Short-Term Investments $1.394B $1.394B $100.2M
Other Short-Term Assets $24.20M $24.20M $6.100M
YoY Change 296.72% 296.72% 64.86%
Inventory
Prepaid Expenses
Receivables $15.00M $15.00M $0.00
Other Receivables $10.70M $10.70M $7.400M
Total Short-Term Assets $1.553B $1.553B $703.1M
YoY Change 120.81% 120.81% 141.71%
LONG-TERM ASSETS
Property, Plant & Equipment $12.70M $16.60M $12.30M
YoY Change 3.25% 16.08% 45.47%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $0.00
YoY Change
Other Assets $12.50M $12.50M $0.00
YoY Change -100.0%
Total Long-Term Assets $29.10M $29.10M $14.30M
YoY Change 103.5% 103.5% 32.89%
TOTAL ASSETS
Total Short-Term Assets $1.553B $1.553B $703.1M
Total Long-Term Assets $29.10M $29.10M $14.30M
Total Assets $1.582B $1.582B $717.4M
YoY Change 120.46% 120.46% 137.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $31.30M $31.30M $7.100M
YoY Change 340.85% 340.85% 55.81%
Accrued Expenses $23.10M $24.20M $18.90M
YoY Change 22.22% 22.22% 148.59%
Deferred Revenue $206.2M $22.20M
YoY Change 828.83% 11.11%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $261.7M $261.7M $49.20M
YoY Change 431.91% 432.99% 49.94%
LONG-TERM LIABILITIES
Long-Term Debt $1.000M $1.000M $2.000M
YoY Change -50.0% -50.0% 0.0%
Other Long-Term Liabilities $537.2M $537.2M $24.00M
YoY Change 2138.33% 2138.33% -40.15%
Total Long-Term Liabilities $1.000M $538.2M $2.000M
YoY Change -50.0% 1970.0% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $261.7M $261.7M $49.20M
Total Long-Term Liabilities $1.000M $538.2M $2.000M
Total Liabilities $799.9M $799.9M $75.20M
YoY Change 963.7% 965.11% 0.33%
SHAREHOLDERS EQUITY
Retained Earnings -$682.9M -$491.9M
YoY Change 38.83% 32.03%
Common Stock $0.00 $0.00
YoY Change -100.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $781.7M $781.7M $642.2M
YoY Change
Total Liabilities & Shareholders Equity $1.582B $1.582B $717.4M
YoY Change 120.46% 120.46% 137.83%

Cashflow Statement

Concept 2021 Q4 2021 2020 Q4
OPERATING ACTIVITIES
Net Income -$53.00M -$191.0M -$41.55M
YoY Change 27.55% 60.1% 97.41%
Depreciation, Depletion And Amortization $1.288M $4.800M $1.060M
YoY Change 21.51% 50.0% 96.3%
Cash From Operating Activities -$35.75M $559.4M -$29.02M
YoY Change 23.21% -723.63% 79.36%
INVESTING ACTIVITIES
Capital Expenditures -$1.895M $4.700M -$1.860M
YoY Change 1.88% -26.56% 4.49%
Acquisitions
YoY Change
Other Investing Activities -$113.7M -$1.309B $58.72M
YoY Change -293.7% -866.78% -162.71%
Cash From Investing Activities -$115.6M -$1.314B $56.86M
YoY Change -303.37% -899.51% -159.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $0.00
YoY Change
Cash From Financing Activities 3.999M $278.6M 471.5M
YoY Change -99.15% -44.79% 333.88%
NET CHANGE
Cash From Operating Activities -35.75M $559.4M -29.02M
Cash From Investing Activities -115.6M -$1.314B 56.86M
Cash From Financing Activities 3.999M $278.6M 471.5M
Net Change In Cash -147.4M -$475.6M 499.4M
YoY Change -129.51% -182.11% -17143.69%
FREE CASH FLOW
Cash From Operating Activities -$35.75M $559.4M -$29.02M
Capital Expenditures -$1.895M $4.700M -$1.860M
Free Cash Flow -$33.86M $554.7M -$27.16M
YoY Change 24.67% -677.21% 88.61%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001655759
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2021Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2021Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2021Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2021Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2021Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2021Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2021 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2021 us-gaap Lessee Operating Lease Existence Of Option To Terminate
LesseeOperatingLeaseExistenceOfOptionToTerminate
true
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-38672
CY2021 dei Entity Registrant Name
EntityRegistrantName
ARVINAS, INC.
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-2566120
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
5 Science Park
CY2021 dei Entity Address Address Line2
EntityAddressAddressLine2
395 Winchester Ave
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
New Haven
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
CT
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
06511
CY2021 dei City Area Code
CityAreaCode
203
CY2021 dei Local Phone Number
LocalPhoneNumber
535-1456
CY2021 dei Security12b Title
Security12bTitle
Common stock, par value $0.001 per share
CY2021 dei Trading Symbol
TradingSymbol
ARVN
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
false
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
206200000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
22200000 USD
CY2021Q2 dei Entity Public Float
EntityPublicFloat
3457300000 USD
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
53046576 shares
CY2021 dei Auditor Firm
AuditorFirmId
34
CY2021 dei Auditor Name
AuditorName
Deloitte & Touche LLP
CY2021 dei Auditor Location
AuditorLocation
Hartford, Connecticut
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
108300000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
588400000 USD
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
4500000 USD
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
0 USD
CY2021Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1394300000 USD
CY2020Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
100200000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15000000.0 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1000000.0 USD
CY2021Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
10700000 USD
CY2020Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
7400000 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
19700000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6100000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1552500000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
703100000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12700000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12300000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3900000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2000000.0 USD
CY2021Q4 arvn Collaboration Contract Asset And Other Assets
CollaborationContractAssetAndOtherAssets
12500000 USD
CY2020Q4 arvn Collaboration Contract Asset And Other Assets
CollaborationContractAssetAndOtherAssets
0 USD
CY2021Q4 us-gaap Assets
Assets
1581600000 USD
CY2020Q4 us-gaap Assets
Assets
717400000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
31300000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7100000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
23100000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
18900000 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1100000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1000000.0 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
261700000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
49200000 USD
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
534300000 USD
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
22900000 USD
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1000000.0 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2000000.0 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2900000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1100000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
799900000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
75200000 USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
53000000.0 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
53000000.0 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
48500000 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48500000 shares
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
0 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
0 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-682900000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-491900000 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1469200000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1133500000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4600000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
600000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
781700000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
642200000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1581600000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
717400000 USD
CY2021 us-gaap Revenues
Revenues
46700000 USD
CY2020 us-gaap Revenues
Revenues
21800000 USD
CY2019 us-gaap Revenues
Revenues
43000000.0 USD
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
180400000 USD
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
108400000 USD
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
67200000 USD
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
61600000 USD
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
38300000 USD
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
27300000 USD
CY2021 us-gaap Operating Expenses
OperatingExpenses
242000000.0 USD
CY2020 us-gaap Operating Expenses
OperatingExpenses
146700000 USD
CY2019 us-gaap Operating Expenses
OperatingExpenses
94500000 USD
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-195300000 USD
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-124900000 USD
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-51500000 USD
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2500000 USD
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2100000 USD
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1400000 USD
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
1900000 USD
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
3600000 USD
CY2019 us-gaap Investment Income Interest
InvestmentIncomeInterest
4600000 USD
CY2021 us-gaap Interest Expense
InterestExpense
100000 USD
CY2020 us-gaap Interest Expense
InterestExpense
100000 USD
CY2019 us-gaap Interest Expense
InterestExpense
100000 USD
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4300000 USD
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5600000 USD
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5900000 USD
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
CY2020 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
CY2019 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-24700000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-191000000.0 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-119300000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-70300000 USD
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.82
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.82
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.02
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.02
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.13
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.13
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50000000.0 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50000000.0 shares
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39500000 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
39500000 shares
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32900000 shares
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32900000 shares
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-191000000.0 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-119300000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-70300000 USD
CY2021 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-5200000 USD
CY2020 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
500000 USD
CY2019 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
300000 USD
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-196200000 USD
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-118800000 USD
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-70000000.0 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
136600000 USD
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
20100000 USD
CY2019 arvn Issuance Of Common Stock Underwriters Discounts And Issuance Costs
IssuanceOfCommonStockUnderwritersDiscountsAndIssuanceCosts
7500000 USD
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
137100000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-70300000 USD
CY2019 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2800000 USD
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
300000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
226600000 USD
CY2020 arvn Issuance Of Common Stock Underwriters Discounts And Issuance Costs
IssuanceOfCommonStockUnderwritersDiscountsAndIssuanceCosts
28100000 USD
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
431900000 USD
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
30200000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-119300000 USD
CY2020 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8200000 USD
CY2020 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
500000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
642200000 USD
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
57100000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-191000000.0 USD
CY2021 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
18700000 USD
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
259900000 USD
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-5200000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
781700000 USD
CY2021 us-gaap Profit Loss
ProfitLoss
-191000000.0 USD
CY2020 us-gaap Profit Loss
ProfitLoss
-119300000 USD
CY2019 us-gaap Profit Loss
ProfitLoss
-70300000 USD
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4800000 USD
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3200000 USD
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1600000 USD
CY2021 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-9400000 USD
CY2020 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-1700000 USD
CY2019 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-200000 USD
CY2021 arvn Debt Instrument Loan Forgiveness
DebtInstrumentLoanForgiveness
1000000.0 USD
CY2020 arvn Debt Instrument Loan Forgiveness
DebtInstrumentLoanForgiveness
0 USD
CY2019 arvn Debt Instrument Loan Forgiveness
DebtInstrumentLoanForgiveness
0 USD
CY2021 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-200000 USD
CY2020 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
400000 USD
CY2019 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0 USD
CY2021 arvn Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
1200000 USD
CY2020 arvn Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
900000 USD
CY2019 arvn Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
700000 USD
CY2021 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
400000 USD
CY2020 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
0 USD
CY2019 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
0 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
57100000 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
30200000 USD
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
20100000 USD
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
14000000.0 USD
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1000000.0 USD
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2800000 USD
CY2021 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
3300000 USD
CY2020 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
1200000 USD
CY2019 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
4000000.0 USD
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
13600000 USD
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2400000 USD
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1100000 USD
CY2021 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
12900000 USD
CY2020 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
0 USD
CY2019 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
0 USD
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
23700000 USD
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2000000.0 USD
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1500000 USD
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4200000 USD
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
10800000 USD
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3600000 USD
CY2021 arvn Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-1300000 USD
CY2020 arvn Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-900000 USD
CY2019 arvn Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-600000 USD
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
695500000 USD
CY2020 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-13300000 USD
CY2019 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
4900000 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
559400000 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-89700000 USD
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-40600000 USD
CY2021 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1744600000 USD
CY2020 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
41200000 USD
CY2019 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
256500000 USD
CY2021 arvn Proceeds From Maturities Of Marketable Securities
ProceedsFromMaturitiesOfMarketableSecurities
428500000 USD
CY2020 arvn Proceeds From Maturities Of Marketable Securities
ProceedsFromMaturitiesOfMarketableSecurities
174100000 USD
CY2019 arvn Proceeds From Maturities Of Marketable Securities
ProceedsFromMaturitiesOfMarketableSecurities
169700000 USD
CY2021 arvn Proceeds From Sale Of Marketable Securities
ProceedsFromSaleOfMarketableSecurities
7200000 USD
CY2020 arvn Proceeds From Sale Of Marketable Securities
ProceedsFromSaleOfMarketableSecurities
37800000 USD
CY2019 arvn Proceeds From Sale Of Marketable Securities
ProceedsFromSaleOfMarketableSecurities
0 USD
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4700000 USD
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6400000 USD
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6300000 USD
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1313600000 USD
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
164300000 USD
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-93100000 USD
CY2021 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
CY2020 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
CY2019 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
200000 USD
CY2021 arvn Proceeds From Issuance Of Common Stock In A Public Offering
ProceedsFromIssuanceOfCommonStockInAPublicOffering
264600000 USD
CY2020 arvn Proceeds From Issuance Of Common Stock In A Public Offering
ProceedsFromIssuanceOfCommonStockInAPublicOffering
460000000.0 USD
CY2019 arvn Proceeds From Issuance Of Common Stock In A Public Offering
ProceedsFromIssuanceOfCommonStockInAPublicOffering
137700000 USD
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
4600000 USD
CY2020 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
27700000 USD
CY2019 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
600000 USD
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
18600000 USD
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
8300000 USD
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2800000 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
278600000 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
504600000 USD
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
139700000 USD
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-475600000 USD
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
579200000 USD
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6000000.0 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
588400000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9200000 USD
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
500000 USD
CY2020 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
500000 USD
CY2019 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
200000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9200000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3200000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
112800000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
588400000 USD
CY2021 us-gaap Interest Paid Net
InterestPaidNet
100000 USD
CY2020 us-gaap Interest Paid Net
InterestPaidNet
100000 USD
CY2019 us-gaap Interest Paid Net
InterestPaidNet
100000 USD
CY2021 arvn Number Of Wholly Owned Subsidiaries
NumberOfWhollyOwnedSubsidiaries
4 Subsidiary
CY2021 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
1300000000 USD
CY2021 us-gaap Proceeds From Collaborators
ProceedsFromCollaborators
774000000 USD
CY2021Q4 arvn Cash Cash Equivalents Restricted Cash And Marketable Securities
CashCashEquivalentsRestrictedCashAndMarketableSecurities
1500000000 USD
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
Concentration of Credit Risk The Company maintains its cash in financial institution accounts that may at times exceed federally insured limits. The cash balances in the financial institutions are insured by the Federal Deposit Insurance Corporation ("FDIC") up to $250,000. Cash may also be maintained at commercial institutions that are not insured by the FDIC.
CY2019 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0 USD
CY2020 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0 USD
CY2021 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0 USD
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 operating_segment
CY2021Q2 arvn Base Lease Rent Period
BaseLeaseRentPeriod
P10Y
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
0 USD
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
740500000 USD
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
45100000 USD
CY2021 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
18600000 USD
CY2020 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
18700000 USD
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
46700000 USD
CY2021Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
740500000 USD
CY2021Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
206200000 USD
CY2021Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
232300000 USD
CY2021Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
116700000 USD
CY2021Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
84000000.0 USD
CY2021Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
53000000.0 USD
CY2021Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
48300000 USD
CY2021Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
740500000 USD
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
23400000 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
18400000 USD
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10800000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6100000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12700000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12300000 USD
CY2021 us-gaap Depreciation
Depreciation
4800000 USD
CY2020 us-gaap Depreciation
Depreciation
3200000 USD
CY2019 us-gaap Depreciation
Depreciation
1600000 USD
CY2021Q2 us-gaap Land Subject To Ground Leases
LandSubjectToGroundLeases
160000 sqft
CY2021Q2 us-gaap Pledged Financial Instruments Not Separately Reported Securities For Letter Of Credit Facilities
PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesForLetterOfCreditFacilities
4500000 USD
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
1000000.0 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1500000 USD
CY2021Q4 arvn Lessee Operating Lease Liability Payments Due After Year Two
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearTwo
1500000 USD
CY2021 arvn Lessee Operating Lease Expiration Month And Year
LesseeOperatingLeaseExpirationMonthAndYear
2024-12
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
1400000 USD
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
1200000 USD
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
900000 USD
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3200000 USD
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
600000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1200000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
4200000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
200000 USD
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
4000000.0 USD
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12400000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9000000.0 USD
CY2021Q4 arvn Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
9500000 USD
CY2020Q4 arvn Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
8100000 USD
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1200000 USD
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1800000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
23100000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
18900000 USD
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
0 USD
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
200000 USD
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
200000 USD
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
200000 USD
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
400000 USD
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
1000000.0 USD
CY2021 us-gaap Interest Expense Debt
InterestExpenseDebt
0.0 USD
CY2020 us-gaap Interest Expense Debt
InterestExpenseDebt
100000 USD
CY2019 us-gaap Interest Expense Debt
InterestExpenseDebt
100000 USD
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
57100000 USD
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
30200000 USD
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
20100000 USD
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
55900000 USD
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
52.85
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
27.45
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
13.28
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
46900000 USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
19400000 USD
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1900000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.163
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.001
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.003
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.027
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.041
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.035
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.016
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.017
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.022
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.384
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.233
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.220
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.000
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.000
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
97000000.0 USD
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
43100000 USD
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
18800000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
10100000 USD
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
15400000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
5000000.0 USD
CY2021Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
10000000.0 USD
CY2020Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
9000000.0 USD
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
3300000 USD
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
100000 USD
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
144500000 USD
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
67300000 USD
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
3600000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
2400000 USD
CY2021Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
1400000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
0 USD
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
5000000.0 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2400000 USD
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
139500000 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
64900000 USD
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0 USD
CY2020Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0 USD
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 USD
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 USD
CY2021 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
1600000 USD
CY2020 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
1800000 USD
CY2019 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
1400000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-191000000.0 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-119300000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-70300000 USD
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50000000.0 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50000000.0 shares
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.13
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39500000 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
39500000 shares
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32900000 shares
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32900000 shares
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.82
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.82
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.02
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.02
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.13
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2600000 shares
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2000000.0 shares
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1200000 shares

Files In Submission

Name View Source Status
0001628280-22-004262-index-headers.html Edgar Link pending
0001628280-22-004262-index.html Edgar Link pending
0001628280-22-004262.txt Edgar Link pending
0001628280-22-004262-xbrl.zip Edgar Link pending
arvn-20211231.htm Edgar Link pending
arvn-20211231.xsd Edgar Link pending
arvn-20211231x10kxex311.htm Edgar Link pending
arvn-20211231x10kxex312.htm Edgar Link pending
arvn-20211231x10kxex321.htm Edgar Link pending
arvn-20211231x10kxex322.htm Edgar Link pending
arvn-20211231_cal.xml Edgar Link unprocessable
arvn-20211231_def.xml Edgar Link unprocessable
arvn-20211231_g1.jpg Edgar Link pending
arvn-20211231_g10.jpg Edgar Link pending
arvn-20211231_g11.jpg Edgar Link pending
arvn-20211231_g12.jpg Edgar Link pending
arvn-20211231_g2.jpg Edgar Link pending
arvn-20211231_g3.jpg Edgar Link pending
arvn-20211231_g4.jpg Edgar Link pending
arvn-20211231_g5.jpg Edgar Link pending
arvn-20211231_g6.jpg Edgar Link pending
arvn-20211231_g7.jpg Edgar Link pending
arvn-20211231_g8.jpg Edgar Link pending
arvn-20211231_g9.jpg Edgar Link pending
arvn-20211231_htm.xml Edgar Link completed
arvn-20211231_lab.xml Edgar Link unprocessable
arvn-20211231_pre.xml Edgar Link unprocessable
consent-form10kfy21.htm Edgar Link pending
exhibit21_1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending